Drug
Itc 6146ro
Itc 6146ro: highest development phase Phase 1, developed by IntoCell, Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- IntoCell, Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| ITC-6146RO NCT07423117 | Phase 1 | Metastatic Castration-resistant Prostate Cancer |
Latest
No recent events.
Follow Itc 6146ro on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.